Cost-Benefit of Real-Time Multiplex PCR Testing of SARS-CoV-2 in German Hospitals
- PMID: 36834141
- PMCID: PMC9960777
- DOI: 10.3390/ijerph20043447
Cost-Benefit of Real-Time Multiplex PCR Testing of SARS-CoV-2 in German Hospitals
Abstract
Background: The current Omicron COVID-19 pandemic has significant morbidity worldwide.
Objective: Assess the cost-benefit relation of implementing PCR point-of-care (POCT) COVID-19 testing in the emergency rooms (ERs) of German hospitals and in the case of inpatient admission due to other acute illnesses.
Methods: A deterministic decision-analytic model simulated the incremental costs of using the Savanna® Multiplex RT-PCR test compared to using clinical judgement alone to confirm or exclude COVID-19 in adult patients in German ERs prior to hospitalization or just prior to discharge. Direct and indirect costs were evaluated from the hospital perspective. Nasal or nasopharyngeal swabs of patients suspected to have COVID-19 by clinical judgement, but without POCT, were sent to external labs for RT-PCR testing.
Results: In probabilistic sensitivity analysis, assuming a COVID-19 prevalence ranging between 15.6-41.2% and a hospitalization rate between 4.3-64.3%, implementing the Savanna® test saved, on average, €107 as compared to applying the clinical-judgement-only strategy. A revenue loss of €735 can be avoided when SARS-CoV-2 infection in patients coming unplanned to the hospital due to other acute illnesses are excluded immediately by POCT.
Conclusions: Using highly sensitive and specific PCR-POCT in patients suspected of COVID-19 infection at German ERs may significantly reduce hospital expenditures.
Keywords: COVID-19; SARS-CoV-2; antigen testing; cost–benefit analysis; point-of-care; real-time reverse transcriptase polymerase chain reaction (RT-PCR).
Conflict of interest statement
R.D. received a fee for consultancy and for speaking at a microbiological congress supported by Quidel Inc. A.N. declares no conflict of interest.
Figures


Similar articles
-
Point-of-care COVID-19 antigen testing in German emergency rooms - a cost-benefit analysis.Pulmonology. 2022 May-Jun;28(3):164-172. doi: 10.1016/j.pulmoe.2021.06.009. Epub 2021 Jul 6. Pulmonology. 2022. PMID: 34315687 Free PMC article.
-
Rapid Point-of-Care Influenza Testing for Patients in German Emergency Rooms - A Cost-Benefit Analysis.J Health Econ Outcomes Res. 2019 Dec 26;6(3):203-212. doi: 10.36469/001c.11206. eCollection 2019. J Health Econ Outcomes Res. 2019. PMID: 32685592 Free PMC article.
-
Cost-Benefit Analysis of Real-Time Influenza Testing for Patients in German Emergency Rooms.Int J Environ Res Public Health. 2019 Jul 3;16(13):2368. doi: 10.3390/ijerph16132368. Int J Environ Res Public Health. 2019. PMID: 31277347 Free PMC article.
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. PMID: 32997361 Updated.
-
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839. Mikrobiyol Bul. 2020. PMID: 32755524 Review. Turkish.
Cited by
-
The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania.Diagnostics (Basel). 2024 Mar 16;14(6):631. doi: 10.3390/diagnostics14060631. Diagnostics (Basel). 2024. PMID: 38535051 Free PMC article. Review.
References
-
- World Health Organization Weekly Epidemiological Update on COVID-19. [(accessed on 2 November 2022)]. Available online: https://www.who.int/publications/m/item/weekly-epidemiological-update-on....
-
- Robert Koch Institute COVID-19: Number of Cases in Germany and Worldwide. [(accessed on 7 November 2022)]. Available online: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Fallzahlen....
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous